Pulmonary Rehabilitation in Multimorbidity and Multiple Disabilities
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2013, Vol 2, Issue 2
Abstract
In Chronic Obstructive Pulmonary Disease (COPD) patients, it has been proven that Pulmonary Rehabilitation (PR) helps in increasing the exercise ability, in easing the difficulty in breathing, in improving Health-Related – Quality of Life (HR-QoL) and in decreasing the period in hospital and the utilization of medical resources.1
Authors and Affiliations
Masahiro Kohzuki
Keywords
Related Articles
- EP ID EP550081
- DOI 10.17140/PRRMOJ-2-e001
- Views 113
- Downloads 0
Balloon Pulmonary Angioplasty (BPA) and Rehabilitation for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH) has a poor prognosis because of increased pulmonary arterial pressure (PAP) causing pulmonary hypertension and progressive right-sided heart failure.1,2 Typical sympt...
Recent Advances in Pulmonary Rehabilitation for Patients with COPD
Pulmonary rehabilitation (PR) is a non-pharmacologic therapy that has emerged as a standard of care for patients with chronic obstructive pulmonary disease (COPD). It is a comprehensive, multidisciplinary, patient-center...
Effects of the Resisted Exercise in the Respiratory Function of Individuals With Hemiparesis after Stroke
Objective To compare the effects of resisted exercise in lungs volume and capacity and strength of the respiratory muscles on individuals with hemiparesis after a stroke. Methods Ten individuals with hemiparesis caused b...
Tuberculosis in Pregnancy: Delayed Diagnosis, Lost Lives
Tuberculosis still remains an important global health disease, killing many people annually. Yet it is a preventable cause of death. Maternal mortality rates due to tuberculosis and HIV/AIDS in Sub-Saharan Africa make up...
An Unbalanced Exon-Expression qPCR-based Assay for Detection of ALK Translocation (Fusion) in Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) constitutes 85-90% of all lung cancer. Accurate diagnosis and selection of targeted therapies in lung cancer depends on robust detection of the molecular events that underlie its pathog...